Genetics of psoriasis: the potential impact on new therapies.
about
Serum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureyleneGenome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at RELWhole-exome SNP array identifies 15 new susceptibility loci for psoriasis.An epidemiological study on trigger factors and quality of life in psoriatic patientsCathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis.Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS.Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab.Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2The future of genetic testing for drug response.Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis.Profile of Tumour Necrosis Factor Alpha -308 G/A Gene Polymorphism in Psoriatic Patients in Karnataka, India.Emerging oral drugs for psoriasis.Tumor necrosis factor alpha gene promoter -238G/A polymorphism increases the risk of psoriasis vulgaris in Indian patients.Characterisation of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1.HLA-C and TNF gene polymorphisms are associated with psoriasis in Brazilian patients.IL-10 implications in psoriasis.Current concepts in the pathogenesis of psoriasis.A brief summary of clinical types of psoriasis.
P2860
Q24803476-B97E12B1-0837-4237-B253-B8E05FE8EB4EQ28943423-A88B9CCF-EBD2-47AC-A7C1-EB2B0DF3C7D0Q30373501-55E497D3-94DD-4273-861F-2B57D5F0879FQ34035874-2FEA5CCE-C922-4ECF-AC5F-9EFB459E0C25Q34268735-77A8CD16-DFDD-48B8-BB57-9EF6F90F3F7DQ34414021-5648B597-EFFF-4CB9-BA05-0781C6579C3AQ34502118-4E8CBAFD-7F7E-4375-B78C-17935B2C3740Q35105452-8F0E4EBE-8F75-461B-9D0B-55E002034945Q35236756-BDE83F13-C192-4B9A-BD66-13834C10F4F0Q37693885-E9C0B996-E56D-4A54-B6CB-BB7411941784Q37734084-F0AB8C2A-86F2-47E4-8BD0-25DBD92BB9E2Q38341175-0E7915F8-AB85-4B42-B4B1-FFDEDB0D5EFCQ39017551-ADCB6D09-B4BC-4D58-A174-0AA9CE157ACBQ40862474-2662F173-97B7-46EE-9EFD-2DBE4AF76994Q41215074-9B7C84A6-2CF8-47B5-9443-51D548BE21A5Q42079540-C8178EDF-0DF7-4420-A57E-84EE3305033EQ42283126-83F4ED28-A272-4D27-8672-C006545EAC59Q54940686-1B9379D1-3151-4768-A56B-3CAB35DDDA51
P2860
Genetics of psoriasis: the potential impact on new therapies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Genetics of psoriasis: the potential impact on new therapies.
@ast
Genetics of psoriasis: the potential impact on new therapies.
@en
Genetics of psoriasis: the potential impact on new therapies.
@nl
type
label
Genetics of psoriasis: the potential impact on new therapies.
@ast
Genetics of psoriasis: the potential impact on new therapies.
@en
Genetics of psoriasis: the potential impact on new therapies.
@nl
prefLabel
Genetics of psoriasis: the potential impact on new therapies.
@ast
Genetics of psoriasis: the potential impact on new therapies.
@en
Genetics of psoriasis: the potential impact on new therapies.
@nl
P1476
Genetics of psoriasis: the potential impact on new therapies.
@en
P2093
Jonathan N Barker
P356
10.1016/S0190-9622(03)01135-6
P407
P433
P577
2003-08-01T00:00:00Z